⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MNKD News
Mannkind Corporation
Form 8-K
sec.gov
MNKD
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
MNKD
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
globenewswire.com
MNKD
UTHR
MannKind to Report First Quarter 2026 Financial Results on May 6, 2026
globenewswire.com
MNKD
Oryon Cell Therapies Appoints Burkhard Blank, M.D., as Chief Medical Officer
businesswire.com
MNKD
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
prnewswire.com
MESO
LGVN
LCTX
MNKD
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026
globenewswire.com
MNKD
MannKind Announces Settlement of Convertible Senior Notes
globenewswire.com
MNKD
MannKind to Participate in Upcoming Investor Conferences
globenewswire.com
MNKD
Form 8-K
sec.gov
MNKD